KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Interest Expenses (2016 - 2025)

Elevance Health (ELV) has disclosed Interest Expenses for 17 consecutive years, with $366.0 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 7.65% to $366.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 18.31% year-over-year, with the annual reading at $1.4 billion for FY2025, 18.31% up from the prior year.
  • Interest Expenses for Q4 2025 was $366.0 million at Elevance Health, up from $351.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $366.0 million in Q4 2025, with the low at $192.0 million in Q1 2021.
  • Average Interest Expenses over 5 years is $263.3 million, with a median of $259.0 million recorded in 2023.
  • The sharpest move saw Interest Expenses decreased 1.03% in 2021, then soared 31.27% in 2024.
  • Over 5 years, Interest Expenses stood at $200.0 million in 2021, then increased by 14.5% to $229.0 million in 2022, then rose by 13.1% to $259.0 million in 2023, then soared by 31.27% to $340.0 million in 2024, then rose by 7.65% to $366.0 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $366.0 million, $351.0 million, and $341.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.